Skip to main content
. Author manuscript; available in PMC: 2018 Mar 12.
Published in final edited form as: Pathog Immun. 2018 Feb 19;3(1):2–18. doi: 10.20411/pai.v3i1.228

Table 1.

Clinical data for HBV+ individuals

Clinical characteristic Measurement
Age (years) 36 (30.75, 40.25)
Sex 70.6 % Male
29.4 % Female
Time since jaundice (days) 19 (14, 22)
ALT (IU/ml) 598.5 (260, 985)
AST (IU/ml) 244 (154.5, 735)
Serum HBV proteins (IU/ml)
 HBsAg 271.8 (240, 329.4)

16/16 detectable HBsAg (2 UD)
 HBeAg 0.64 (0.305, 6.205)

7/16 with detectable HBeAg (2UD)
Serum antibodies (mIU/ml)
 Anti-HBcAg IgM 3.97 (2.92, 14)

14/14 with anti-HBcAg IgM (4 UD)
 Anti-HBsAg IgG 0.2 (0, 5)

9/16 with anti-HBsAg (2 UD)
 Anti-HBeAg IgG 0.238 (0.141, 1.03)

4/15 with anti-HBeAg (3 UD)

UD = undetermined; IU/mL = International units per milliliter of blood; mIU/mL = milli-international units per milliliter blood